Koers AXM Pharma, Inc. Other OTC
Aandelen
AXMP
US0024571095
Farmaceutische producten
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 10,41K 9,58K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda L. Forster
CEO | Chief Executive Officer | 55 | 02-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Emmanuel Neossi
CHM | Chairman | - | 30-06-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,36% | 709 mld. | |
+30,77% | 595 mld. | |
-1,60% | 367 mld. | |
+20,07% | 334 mld. | |
+6,04% | 289 mld. | |
+14,77% | 239 mld. | |
+9,13% | 211 mld. | |
-3,97% | 203 mld. | |
+9,27% | 171 mld. |